1. Drug-induced liver injury associated with dacomitinib: A case report
   Xuanxuan Wang et al, 2022, Frontiers in Oncology CrossRef
2. Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
   Yufeng Li et al, 2023, Cell Communication and Signaling CrossRef
3. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells
   Ye Jin Lim et al, 2024, Molecules CrossRef